December 4, 2024 12:46 PM EST

Bluebird and Vertex's sickle cell gene therapies to kick off new Medicaid access model

Zachary Brennan

Senior Editor

The Biden Administration said Wednesday that it has secured agreements with Vertex Pharmaceuticals and bluebird bio for their sickle cell disease gene therapies to be …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Bluebird and Vertex's sickle cell gene therapies to kick off new Medicaid access model

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Updated: CEO of UnitedHealth insurance unit shot and killed in New York in what police call ‘a brazen, targeted ...

Lilly beats Novo in bellwether head-to-head weight loss study

As 23andMe struggles, another genetic testing company bets on drug discovery

Moderna CEO defends pandemic prep efforts with critics set to enter Trump’s administration

Trade group tells FDA that semaglutide is not too 'complex' for compounding

Ro’s weight loss business more than doubled in the last year. Now it’s trying to prove its program works

Blue­bird and Ver­tex's sick­le cell gene ther­a­pies to kick off new Med­ic­aid ac­cess mod­el

Zachary Brennan

Senior Editor

Sign up to read this article for free.

more like this

Up­dat­ed: CEO of Unit­ed­Health in­sur­ance unit shot and killed in New York in what po­lice call ‘a brazen, tar­get­ed ...

Lil­ly beats No­vo in bell­wether head-to-head weight loss study

As 23andMe strug­gles, an­oth­er ge­net­ic test­ing com­pa­ny bets on drug dis­cov­ery

Mod­er­na CEO de­fends pan­dem­ic prep ef­forts with crit­ics set to en­ter Trump’s ad­min­is­tra­tion

Trade group tells FDA that semaglu­tide is not too 'com­plex' for com­pound­ing

Ro’s weight loss busi­ness more than dou­bled in the last year. Now it’s try­ing to prove its pro­gram works

Bluebird and Vertex's sickle cell gene therapies to kick off new Medicaid access model

Updated: CEO of UnitedHealth insurance unit shot and killed in New York in what police call ‘a brazen, targeted ...

Lilly beats Novo in bellwether head-to-head weight loss study

As 23andMe struggles, another genetic testing company bets on drug discovery

Moderna CEO defends pandemic prep efforts with critics set to enter Trump’s administration

Trade group tells FDA that semaglutide is not too 'complex' for compounding

Ro’s weight loss business more than doubled in the last year. Now it’s trying to prove its program works